Colon Cancer Clinical Trial
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.
Age ≥18 years
Histologically confirmed stage II or III colon cancer
Completed surgical resection with curative intent
Plan to initiate an oxaliplatin-based chemotherapy regimen
Engage in <60 minutes per week of moderate- to vigorous-intensity structured aerobic exercise
No planned major surgery during the study period
Readiness to exercise, as determined by a modified version of the Physical Activity Readiness Questionnaire
Can walk 400 meters
Can read and speak English
Ability to provide written informed consent
Provide written approval by qualified healthcare professional
Willing to be randomized
Evidence of metastatic colon cancer
Concurrently actively treated other (non-colon) cancer
Currently pregnant, breastfeeding, or planning to become pregnant within the next 24 weeks
Currently participating in another study with competing outcomes
Any other condition that, in the opinion of the investigator, would preclude participation or successful compliance with the protocol
Any other situation that, in the opinion of the investigator, would negatively impact subject safety or successful compliance with the protocol
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Oakland California, 94612, United States More Info
Baton Rouge Louisiana, 70808, United States More Info
Boston Massachusetts, 02215, United States More Info
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.